The report covers forecast and analysis for the endocrine testing market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the endocrine testing market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the endocrine testing market on a global level.
This report offers comprehensive coverage on global endocrine testing market along with, market trends, drivers and restraints of endocrine testing market. This report included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the endocrine testing market has also been included. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate and general attractiveness. This report is prepared using data sourced from in-house databases, secondary and primary research team of industry experts.
The study provides a decisive view on the endocrine testing market by segmenting the market based on test, technology, end-user and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The test market covered under this study includes Dehydroepiandrosterone sulfate (DHEAS), Progesterone, Luteinizing Hormone (LH), Estradiol (E2), Human Chorionic Gonadotropin (hCG), Follicle Stimulating (FSH), testosterone, thyroid prolactin, Thyroid Stimulating Hormone (TSH), cortisol, insulin, and other tests such as gastrin, thymosin, and secretin tests. Some of the key technologies in the market include monoclonal & polyclonal antibody technologies, tandem mass spectrometry, immunoassay, sensors, clinical chemistry technologies, and others. The end-users segmentation includes commercial laboratories, home-based tests, ambulatory care centers, hospitals and other. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global endocrine testing market include Bio Rad Laboratories, DiaSorin, Hoffmann-La Roche Ltd., LabCorp, and Quest Diagnostics, Abbott Laboratories, AB Sciex, Agilent Technologies, Biomedical Technologies and bioMerieux SA.
This report segments the global endocrine testing market as follows:
Global Endocrine Testing Market: Tests Segment Analysis
- Dehydroepiandrosterone sulfate (DHEAS)
- Progesterone
- Luteinizing Hormone (LH)
- Estradiol (E2)
- Human Chorionic Gonadotropin (hCG), Follicle Stimulating (FSH)
- Testosterone
- Thyroid prolactin
- Thyroid Stimulating Hormone (TSH), cortisol, insulin
- Other Test
Global Endocrine Testing Market: Technology Segment Analysis
- Monoclonal & Polyclonal Antibody Technologies
- Tandem Mass Spectrometry
- Immunoassay
- Sensors
- Clinical Chemistry Technologies
- Others
Global Endocrine Testing Market: End-user Segment Analysis
- Commercial Laboratories
- Home-Based Tests
- Ambulatory Care Centers
- Hospitals
- Other Healthcare Settings
Global Endocrine Testing Market: Regional Segment Analysis
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
